Abstract
Myocardial reperfusion during the course of an acute myocardial infarction improves patients' short- and long-term prognosis; coronary blood flow is successfully re-established while preserving a large amount of at-risk muscle. Clinical evolution, however, varies. Presence of residual ischemia or viable myocardial tissue affects a patient's prognosis. Assessment by noninvasive methods allows better prognostic stratification. Cardiac-gated SPECT provides appropriate parameters to support treatment selection and monitoring of these patients. Assess the prognostic value--ability to predict occurrence of major cardiac events--of perfusion and cardiac function obtained by myocardial perfusion scintigraphy in myocardial infarction patients treated by any myocardial reperfusion method, whether pharmacological or surgical. Forty patients were included, mean age 58.8 ± 9 years, diagnosed with myocardial infarction. Participants were divided into two groups: primary percutaneous transluminal coronary angioplasty (15) or thrombolysis (25). All received myocardial perfusion scintigraphy with cardiac-gated SPECT to assess perfusion and left ventricular function, and were followed for six months with telephone interviews and review of clinical records. In the 11 patients who had major cardiac events within six months of followup, a nonsignificant increase in perfusion defect extent was seen post reperfusion. Six (54.5%) of those with major cardiac events had anterior perfusion defects. In functional parameters, a significant increase in end-diastolic and end-systolic volumes and decrease in left ventricular ejection fraction were observed post stress (p = 0.006) and at rest (p = 0.001). Post-stress end-diastolic volume of ≥70 mL had a higher prognostic value for major cardiac events [sensitivity 100%; specificity 89%, area under ROC curve 0.835 (CI 0.702-0.969), p = 0.001]. Cardiac-gated SPECT is useful to identify variables (including left ventricular systolic dysfunction and dilation of left cavities, particularly left end-systolic volume of >70 mL) predictive of major cardiac events in reperfused patients, independent of treatment modality.
Highlights
Myocardial reperfusion during the course of an acute myocardial infarction improves patients’ short- and long-term prognosis; coronary blood flow is successfully re-established while preserving a large amount of at-risk muscle
Post-stress end-diastolic volume of ≥70 mL had a higher prognostic value for major cardiac events [sensitivity 100%; specificity 89%, area under ROC curve 0.835 (CI 0.702–0.969), p = 0.001]
The study looked at the 40 patients treated with thrombolysis or primary percutaneous transluminal coronary angioplasty (PTCA) who were referred to nuclear medicine services by their attending cardiologists for perfusion studies from to 45 days post acute myocardial infarction (AMI); patients were excluded if they had conditions that complicate perfusion study interpretation or other known cardiac diseases
Summary
Myocardial reperfusion during the course of an acute myocardial infarction improves patients’ short- and long-term prognosis; coronary blood flow is successfully re-established while preserving a large amount of at-risk muscle. Current acute myocardial infarction (AMI) treatment has improved patients’ short- and long-term prognoses. The main therapies work by treating thrombus formation and progression of platelet aggregation and by reducing ischemia, preserving cardiac muscle.[1] Early application of myocardial reperfusion techniques—initially thrombolytic drugs and later percutaneous transluminal coronary angioplasty (PTCA)—[2] increases the chances of success in re-establishing coronary circulation. Patient progress after reperfusion is not always satisfactory; in the first year, there can be complications such as angina recurrence, AMI, need for reintervention, or death from cardiac causes. Identification of which reperfused patients may suffer a more unfavorable evolution enables implementation of tailored treatment strategies.[4,5]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.